Evidence map›Paper›PMID 31359110›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2019

Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.

Nicolas Raposo, Mélanie Planton, Pierre Payoux, Patrice Péran, Jean François Albucher, Lionel Calviere, Alain Viguier, Vanessa Rousseau, Anne Hitzel, François Chollet and 3 more

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Nicolas RaposoDepartment of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France. raposo.n@chu-toulouse.fr.ORCID http://orcid.org/0000-0002-9152-4445
Mélanie PlantonDepartment of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France.
Pierre PayouxToulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.
Patrice PéranToulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.
Jean François AlbucherDepartment of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France.
Lionel CalviereDepartment of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France.
Alain ViguierDepartment of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France.
Vanessa RousseauDepartment of Epidemiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Anne HitzelToulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.
François CholletDepartment of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France.
Jean Marc OlivotDepartment of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France.
Fabrice BonnevilleToulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.
Jérémie ParienteDepartment of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France.
Université Toulouse III - Paul Sabatier · FRCentre Hospitalier Universitaire de Toulouse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEnlarged perivascular spaces in the centrum semiovale (CSO-EPVS) have been linked to cerebral amyloid angiopathy (CAA). To get insight into the underlying mechanisms of this association, we investigated the relationship between amyloid-β deposition assessed by 18F-florbetapir PET and CSO-EPVS in patients with acute intracerebral hemorrhage (ICH).

methodsWe prospectively enrolled 18 patients with lobar ICH (suggesting CAA) and 20 with deep ICH (suggesting hypertensive angiopathy), who underwent brain MRI and 18F-florbetapir PET. EPVS were assessed on MRI using a validated 4-point visual rating scale in the centrum semiovale and the basal ganglia (BG-EPVS). PET images were visually assessed, blind to clinical and MRI data. We evaluated the association between florbetapir PET positivity and high degree (score> 2) of CSO-EPVS and BG-EPVS.

resultsHigh CSO-EPVS degree was more common in patients with lobar ICH than deep ICH (55.6% vs. 20.0%; p = 0.02). Eight (57.1%) patients with high CSO-EPVS degree had a positive florbetapir PET compared with 4 (16.7%) with low CSO-EPVS degree (p = 0.01). In contrast, prevalence of florbetapir PET positivity was similar between patients with high vs. low BG-EPVS. In multivariable analysis adjusted for age, hypertension, and MRI markers of CAA, florbetapir PET positivity (odds ratio (OR) 6.44, 95% confidence interval (CI) 1.32-38.93; p = 0.03) was independently associated with high CSO-EPVS degree.

conclusionsAmong patients with spontaneous ICH, high degree of CSO-EPVS but not BG-EPVS is associated with amyloid PET positivity. The findings provide further evidence that CSO-EPVS are markers of vascular amyloid burden that may be useful in diagnosing CAA.

Indexed as

AgedAmyloid beta-PeptidesAniline CompoundsCerebral Amyloid AngiopathyCerebral HemorrhageEthylene GlycolsFemaleHumansHypertensionMagnetic Resonance ImagingMaleMiddle AgedMultimodal ImagingMultivariate AnalysisPositron-Emission TomographyPrevalenceAmyloid beta-PeptidesAniline CompoundsEthylene GlycolsflorbetapirAmyloid PETCerebral amyloid angiopathyFlorbetapirIntracerebral hemorrhagePerivascular spaces

Identifiers

PMID31359110
OpenAlexW2965533213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.